Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai Justaware
Yantai, Shandong, Chinajustaware.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Yantai Justaware Biotechnology is a clinical-stage biopharmaceutical company based in China, specializing in the discovery and development of innovative antibody-based therapeutics for oncology. The company leverages its proprietary Just-Body platform to engineer next-generation biologics, including bispecific antibodies and antibody-drug conjugates (ADCs). Its lead programs target high-value oncology markers such as Claudin-18.2 and PD-1/CTLA-4, aiming to address unmet medical needs in gastrointestinal and lung cancers. Justaware operates integrated R&D facilities that span from early-stage drug discovery to clinical development.
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugate
- Industry
- Biotech
Beyond the preview
Go deeper on Yantai Justaware.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yantai Justaware.